Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > Off Topic ....Sorta

View:

Post by Red~One on Aug 26, 2022 11:39am

Off Topic ....Sorta

A lot of folks here fell in love with the story that R107, once proven and developed would change the world and make shareholders rich. Part of that story is still alive.

There are many research programs going on now testing Nitric Oxide and 2 have actual products available to retail. Many doctors are doing research to find the key to get around the cytotoxicity problem...and getting close to a solution.

So having said all that, how many here, who still believe the value of Nitric Oxide have studied or invested in any of the other companies developing generated N.O. ?

484